DHS Opioid Detection Resilience Act of 2019
GPTKB entity
Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:appliesTo |
gptkb:U.S._Customs_and_Border_Protection
gptkb:U.S._Department_of_Homeland_Security |
| gptkbp:billColor |
gptkb:H.R._4761
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| gptkbp:focusesOn |
fentanyl
synthetic opioids fentanyl analogues |
| https://www.w3.org/2000/01/rdf-schema#label |
DHS Opioid Detection Resilience Act of 2019
|
| gptkbp:introduced |
Rep. Xochitl Torres Small
|
| gptkbp:introducedIn |
gptkb:House_of_Representatives
2019 |
| gptkbp:publicLawNumber |
Public Law 116-115
|
| gptkbp:purpose |
improve detection of opioids at U.S. borders
|
| gptkbp:requires |
DHS to assess detection equipment
DHS to coordinate with other agencies DHS to provide training for personnel DHS to develop a plan to enhance detection of synthetic opioids |
| gptkbp:signedBy |
gptkb:Donald_Trump
January 21, 2020 |
| gptkbp:bfsParent |
gptkb:Public_Law_116-72
|
| gptkbp:bfsLayer |
7
|